Breaking into the animal health vaccines market requires overcoming high regulatory barriers and providing speed in response to outbreaks and evolving variants. Hanjo Hennemann shares how VEROVACCiNES leveraged a recombinant platform to rapidly design, test, and scale vaccines utilising regulatory pathways for broader and faster market entry.
Session Topics:
Milestone - Platform Technology
Vaccine
Biopharma
Livestock
Late-Stage VC
Regulation
Speaker(s):
Hanjo Hennemann
CEO
VEROVACCiNES
Time:
10.30am - 10.50am
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)